Tagawa Tetsuzo, Ito Kensaku, Fukuzawa Kengo, Okamoto Tatsuro, Fujinaga Atsuro, Kawasaki Takahide, Masuda Takashi, Iwaki Kentaro, Terashi Takahiro, Okamoto Masahiro, Shiromizu Akio, Motohiro Akira, Maehara Yoshihiko
Department of General Thoracic Surgery, Oita Red Cross Hospital, Oita, Japan
Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Anticancer Res. 2017 Jun;37(6):3307-3309. doi: 10.21873/anticanres.11698.
To determine the efficacy of surgery for non-small cell lung cancer in patients who had previously undergone surgery for pancreaticobiliary cancer.
Seven patients who underwent pulmonary resection for primary lung cancer after curative surgery for pancreaticobiliary cancer at our Institution from 2006 to 2016 were retrospectively evaluated.
Five patients had metachronous and two patients had synchronous cancer of pancreaticobiliary and lung origin. The median time between surgeries for the two cancers was 35 months. All patients underwent complete resection of both cancers. The 5-year survival was 68.6% after pulmonary resection. Two patients had recurrence after lung surgery, with a mean recurrence-free interval of 6.5 months.
Surgery should be considered for lung cancer in patients who have undergone curative surgery for pancreaticobiliary cancer.
确定手术治疗对先前接受过胰胆管癌手术的非小细胞肺癌患者的疗效。
对2006年至2016年期间在我院接受胰胆管癌根治性手术后又接受原发性肺癌肺切除手术的7例患者进行回顾性评估。
5例患者为异时性，2例患者为同时性胰胆管和肺源性癌症。两种癌症手术之间的中位时间为35个月。所有患者均对两种癌症进行了根治性切除。肺切除术后5年生存率为68.6%。2例患者肺手术后复发，平均无复发生存期为6.5个月。
对于接受过胰胆管癌根治性手术的肺癌患者，应考虑手术治疗。
